Keyphrases
Chemotherapy
100%
Muscle Strength
100%
Muscle Wasting
100%
Voluntary Exercise
100%
Cisplatin Treatment
100%
Cisplatin-induced
100%
Voluntary Wheel Running
100%
Inflammation
66%
Glucose Tolerance
66%
Cancer Patients
66%
Protein Degradation
66%
Muscle Mass
66%
In Cancer
66%
Cisplatin
66%
Lean Body Mass
66%
Anorexia
66%
Food Intake
33%
Quality of Life
33%
Exercise Training
33%
Weight Loss
33%
Overall Survival
33%
Physical Capacity
33%
Patient-related Outcomes
33%
Muscle Signal
33%
Glycogen Content
33%
Clinical Endpoints
33%
Muscle Glycogen
33%
Anticancer Therapy
33%
Treatment Toxicity
33%
AKT Pathway
33%
Induced Loss
33%
Induced Gene
33%
Muscle Mass Loss
33%
Survival Treatment
33%
Nursing and Health Professions
Muscle Atrophy
100%
Cisplatin
100%
Muscle Mass
42%
Treadmill
42%
Malignant Neoplasm
28%
Inflammation
28%
Body Weight
28%
Muscle Strength
28%
Lean Body Weight
28%
Glucose Tolerance
28%
Anorexia
28%
Quality of Life
14%
Cancer Therapy
14%
Overall Survival
14%
Glycogen Muscle Level
14%
Glycogen Analysis
14%
Body Weight Loss
14%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse
100%
Chemotherapy
100%
Cisplatin
100%
Muscle Atrophy
100%
Malignant Neoplasm
42%
Inflammation
28%
Anorexia
28%
Overall Survival
14%
Biochemistry, Genetics and Molecular Biology
Mouse
100%
Cisplatin
100%
Body Weight
28%
Muscle Strength
28%
Lean Body Weight
28%
Protein Catabolism
28%
Overall Survival
14%
Exercise
14%
Glycogen Muscle Level
14%
Physical Capacity
14%
Akt Signaling
14%
Body Weight Loss
14%